معرفی
Puvanendran Tharmanathan is a Senior Research Fellow and Associate Professor at the University of York, affiliated with the York Trials Unit within the School of Health Sciences. He is a pharmacist with expertise in drug optimisation, antimicrobial resistance, and methodological innovations in clinical trials. As co-investigator on multidisciplinary studies, he contributes to trials within cohorts (TwIC), evidence synthesis, and trial design.
- Biography: Trained in pharmacy, public health, and epidemiology
- Academic Leadership: Trial Steering Committee member for NIHR multi-centre studies
- Research Themes: Drug optimisation, clinical trial methods, participant-reported outcomes
Scientific Contributions span economic evaluations of surgical interventions (e.g., Dupuytren's contracture), antimicrobial stewardship protocols in oncology, and trial methodological innovations. His work bridges pharmacology and clinical trial design, particularly in optimising drug use and patient-reported outcomes.
Teaching and Mentorship include postgraduate supervision of PhD and MSc dissertations, as well as prior lecturing roles in systematic reviews, clinical trial methodology, and evidence-based practice.
Key Projects include BioDrive AFS (antifungal stewardship in leukemia), EXTEND (antibiotic duration studies), PROFHER-2 (shoulder arthroplasty trials), and REASCENT (interferon inhibition in systemic sclerosis). He has also led methodological work on trials within cohorts and end-of-participation events in clinical trials.
Collaboration Networks involve major NIHR-funded trials as principal or co-investigator, with cross-institutional partnerships across clinical, statistical, and health services disciplines.
